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We have performed retina) fluorescein angiography and audiometry in 
32 familial and 7 sporadic cases of facioscapulohumeral muscular dys­
trophy. A mild to moderate retinal vasculopathy, consisting of retinal 
teleangiectasis and microaneursyms, was present in 18 of 37 evaluable 
angiograms (49%); 5 patients had minimal changes and 14 angiograms 
(38%) were normal. High frequency hearing loss was found in 25 (64%) 
out of 39 patients. Retinal changes were absent in 5 of 18 families (6 
cases examined), and after correction for age and sex, hearing function 
was normal in 5 of 19 families (7 cases examined). Age and severity of 
the myopathy did not have a clear relationship with the retinal vascu­
lopathy or the hearing loss. There were no differences between families 
in which the myopathy was linked to chromosome 4q35 and families in 
which linkage could not be proven, Minimal retinal vascular changes 
and high tone hearing loss can be observed occasionally in the normal 
population. Therefore, although retinal vasculopathy and hearing loss 
are part of the clinical picture of FSHD, these signs cannot be accepted 
as decisive criteria for FSHD in clinically equivocal cases. © 1995 John 
Wiley & Sons, Inc.
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ON THE SIGNIFICANCE OF RETINAL 
VASCULAR DISEASE AND HEARING 
LOSS IN FACIOSCAPULOHUMERAL 
MUSCULAR DYSTROPHY
G.W. PADBERG, NID, O.F. BROUWER, MD, R.J.W. de KEIZER, MD, 
G. DIJKMAN, MD, C. WIJMENGA, PhD, J J . GROTE, MD, and 
R.R. FRANTS, PhD
Facioscapulohum eral muscular dystrophy 
(FSHD) is an autosomal-dominant myopathy with 
a variable age of onset, and a variable rate of pro­
gression. The disease starts in the facial and shoul­
der girdle muscles and has a fairly uniform pattern 
of further spread of muscle involvement,16,17 sub­
sequently affecting the abdominal muscles, the 
foot extensors, and upper arm muscles, followed
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by the pelvic girdle and lower arm muscles. The 
gene for FSHD has been located on the tip of the 
long arm of chromosome 4 in the band 4q35 by 
linkage analysis.23,24
Extramuscular involvement in FSHD has been 
the subject of debate for many years. A retinal vas­
culopathy in association with sensorineural deaf­
ness and FSHD was originally described as an in­
dependent entity18 (MIM 216350) and later as a 
special form of FSHD7,10,15,21,27 until Fitzsimons et 
al. observed retinal vascular changes by fluorescein 
angiography in 48 of 64 patients with the common 
picture of FSHD.5 Only one of these patients had 
visual loss, and the retinal vascular disease was vis­
ible by fundoscopy in 3 patients only. The vascu­
lopathy seen on fluorescein angiography consisted 
of irregularities of the vascular wall, teleangiecta­
sis, capillary microaneurysms with retinal edema 
and exudates, and capillary occlusions. The au­
thors recognized a mild form of the vasculopathy 
as a simplification of the retinal bed with fewer, 
longer and wider capillaries than normal, visible in 
the peripheral retina only. Also, they found retinal
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vascular changes in 3 parents of 4 sporadic cases, They all underwent stereoscopic direct and indi-
suggesting that the retinopathy might serve to de- rect fundoscopy. Black and white photographs and 
tect nonpenetrant gene carriers.
Sensorineural deafness has frequently been ob­
served in association with FSHD,22 but often un­
color slides were made to distinguish drusen, exu­
dates, hemorrhages, and pigm ent spots. If ab­
normalities were observed, the abnormal eye was
usual features such as a severe muscle disease, an photographed first during the fluorescein angiog- 
autosomal-recessive pattern o f inheritance, or raphy. In the other cases, the eye to be photo­
mental retardation have been reported as well, graphed first was chosen at random. One patient
^  i  ♦ 1 r-  i  1
supporting the idea of genetic heterogeneity of 
FSHD.7,15’21’27,28 Recently, we demonstrated in a 
large patient population that high frequency hear­
ing loss is part of the common picture of FSHD.1
*
underwent angiography of both eyes separately. In 
all other patients both eyes were studied in one 
examination. The routine fluorescein angiography 
was performed with a 30° angle camera, photo-
As the extent and the significance of the retinal graphing the early phase o f the macula of one eye 
vascular changes and the sensorineural hearing first, moving to the lateral peripheral retina of the 
loss were debated and the possibility of clinical, same eye (Fig. 1), and then to the other eye in the
same sequence.
All angiograms were reviewed by four experi­
enced ophthalmologists who were familiar with the 
expected abnormalities. When judged technically 
sufficient, each angiogram was given a final score 
based on the most abnormal fundus. The score was 
labeled “negative” if an angiogram was considered 
to be without abnormalities; “minimally and equiv­
ocally abnormal” if some teleangiectasis and a few 
hyperfluorescent patches, possibly microaneu­
rysms, were present such as in Figure 4; “mildly 
abnormal” if central or perifoveal teleangiectasis 
were present, with a mild coarse pattern of the 
capillaries and some isolated hemorrhages; and 
“moderately abnormal” if prominent teleangiecta-
and therefore genetic heterogeneity was discussed, 
we tried to examine patients from a large number 
of families. After informed consent was obtained, 
we studied 32 familial and 7 sporadic cases, and 8 
healthy parents of 4 sporadic cases.
PATIENTS AND METHODS
Eight healthy parents of 4 sporadic cases, and 39 
patients, fulfilling all criteria of FSHD, including 
EMG and muscle biopsy in at least one patient per 
pedigree,17 consented to routine ophthalmological 
examination, fluorescein angiography, and clinical 
audiometry. Among the 26 males (mean age 45.2 
years) and 13 females (mean age 43.5 years) 32 
cases were familial and 7 sporadic. The familial 
cases came from 19 families (Table 1). In three 
families (LE, U, VE) with 2 or more affected sibs in 
one sibship, autosomal-dominant inheritance 
could not be proven. In two of these families (LE, 
U) one parent could not be examined; in family 
VE both parents were healthy and nonpenetrance 
in one parent or germ-cell mosaicism was assumed. 
The remaining 16 families showed a clear autoso­
mal-dominant pattern of inheritance. In 12 fami­
lies, FSHD was linked to chromosome 4 mark­
ers23,24 and associated with specific fragments 
recognized by p l3 E -ll .25,26 In seven families, a 
chromosome 4 association could not be proven. 
For various reasons, DNA was not available from 
families N, U, VI, and VE. Family R has been dis­
cussed before,24 and in two other small families 
(KL and LU) linkage could not be proven, but 
could not be excluded either (Table 1). In the spo­
radic cases one to five chromosome 4-associated 
DNA rearrangements were found.26,26 DNA was 
not available from sporadic cases 6 and 7.
Patients were questioned about symptoms of 
diseases with possible retinal vascular pathology 
and about hereditary ophthalmological diseases.
FIGURE 1. Case AV14. Fluorescein angiogram of retinal pe 
riphery showing hyperfluorescence of a rather coarse (slm 
plified) capillary bed (*) and some microaneurysms.
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sis or beading of the capillaries, capillary occlusions 
with fields of occlusion, and microaneurysms with 
isolated exudates were found (Figs. 2 and 3). The 
designation “severely abnormal” was reserved for 
the Coats-like picture with large exudates and 
hemorrhages and capillary occlusions as reported 
by Fitzsimons et al.5 Our coding of mild and mod­
erate changes is comparable to the light and mild 
changes in the series of Caswell et a l2 A consecu­
tive control series of 130 fluorescein angiograms 
made for other reasons than a clinical suspicion of 
retinal vascular disease was scored in a similar fash­
ion.
All patients were asked about noise trauma and 
the use of ototoxic drugs and they all underwent 
otoscopic examination. Audiograms were obtained 
in sound-proof facilities. Tone audiograms were 
corrected for age and sex using standardized ta­
bles.19
RESULTS
None of the patients suffered from a disease that 
could lead to retinal vascular and capillary pathol­
ogy except patient JIV3 who had late onset diabe­
tes mellitus. His angiogram was judged minimally 
abnormal (Table 1).
No patient had visual complaints other than re­
fraction-related symptoms. Seven of the first 10 
patients who underwent specific corneal examina­
tion showed mild corneal lesions, which were at-
jilt
FIGURE 3. Sporadic case 6. Fluorescein angiogram of the 
right eye showing solitary microaneurysms and groups of 
aneurysms in the area bordered by the temporal vessels.
FIGURE 2. Case GIII20. Fluorescein angiogram of the left eye 
showing perimacular teleangiectasis, microaneurysms, and 
patchy capillary hyperfluorescence.
tributed to orbicularis oculi weakness. All patients 
underwent careful fundoscopy which revealed vas­
cular irregularities in 4 patients. Three patients 
had one or two small exudates, and 2 patients had 
a small hemorrhage. No patient showed the severe 
picture reported by Fitzsimons et al.5
From the 32 familial cases, two angiograms 
(HV16, LEII7) were judged technically insuffi­
cient. Therefore, 30 angiograms from 18 families 
could be scored (Table 2). The five families (C, I, 
L, R, and U) with normal angiograms contributed 
six angiograms; six other normal angiograms were 
observed in sibs from families with abnormal an­
giograms. A normal angiogram was seen in patient 
JIV10, while the family was scored equivocally ab­
normal because of the angiogram in JIV3. Four­
teen patients (47%), coming from 10 families 
(56%), revealed a mildly or moderately abnormal 
fluorescein angiogram (Figs. 1-4). We did not ob­
serve the severe, Coats-like picture. There were 
differences in the extent of involvement between 
the two eyes. This might be due to the technical 
problem of making early photographs of both eyes 
after a single injection of fluorescein. Vascular 
changes were observed in the parafoveal and peri­
macular field in 7 cases, in the periphery in 4 cases, 
and in both areas in 3 patients. Capillary microan­
eurysms were present perimacularly in 7 patients, 
and peripherally in only 1. Six patients had vascu­
lar occlusions; only 4 showed small exudates.
Retinal Vascular Disease and Hearing Loss in FSHD MUSCLE & NERVE Supplement 2 1995 S75
Table 1. Retinal vascular pathology and hearing loss in 
facioscapulohumeral muscular dystrophy.
Retinal Hearing
Patient S ex Age Onset* vasculopathyt loss4




AV10 M 33 15 + ---
AV14 M 40 14 + + L
buh N/l 68 20 RL
BIII6 F 53 16 - RL
BIV4 M 34 24 — RL
CIII1 M 44 21 — L
EIV1 M 46 16 j: L
EV1 M 24 14 + ---
GII 117 M 49 19 + + ---
GJII2Q M 40 20 + + RL
HV7 M 54 14 + RL
HV8 M 47 35 + + RL
HV16 M 48 8 Tl§ L
IV7 M 69 20 — ---
iv m F 32 6 — ---
JIV3 M 62 18 ± RL
JIV10 F 61 24 R
LIV44 F 53 19 — RL
VSI15 M 3B 35 + RL
OJII4 M 44 10
LEII7 F 53 16 I I RL
Chromosome 4 relation not proven 
NIMIO M 66 20 +
NI 111 2 F 63 6 — RL
RI 16 M 54 16 — ---
Ul 13 M 43 5 — RL
KLM 15 F 69 55 + + RL
KLIV18 F 32 29 RL
VIIII1 M 27 14 + RL
VEII5 M 43 H ---
VEUT M 40 19 + ---
LU 11119 p 30 1Ì ---
Sporadic cases of FSHD and 4 parent pairs
1 F 19 2 + RL
2 F 31 10 H— h L
3 M 39 18 dt ---
4 F 35 10 — ---
5 M 31 16 — RL
6 M 62 17 + + RL
7 M 31 16 L
P1H M 46 — RL
M1 F 46 — RL
P2 M 58 RL
M2 F 57 — _
P3 M 66 + RL
M3 F 63 + L
P4 M 68 + RL
M4 F 65 + ^—
'Onset of symptoms of FSHD by history,
f  Grading of the retinal vascuiopathy; normal; ±, equivocal; + , 
mildly abnormal; + +, moderately abnormal.
= right ear deficit; L = (eft ear deficit,
§TechnicaHy insufficient.
1Denotes an asymptomatic case.
11P7 father of sporadic case 1.
When chromosome 4—associated FSHD pa­
tients were compared with patients in whom chro­
mosome 4 association was not proven, no signifi­
cant difference in the numbers of abnormal 
angiograms was observed (Table 2). A similar ten­
dency was present in the sporadic cases. Sporadic 
cases 1—5 had shown the rearranged DNA frag­
ments,25,26 while no DNA was available from cases 
6 and 7, demonstrating again that the clinical pic­
ture is the same in chromosome 4 proven and not- 
proven FSHD patients.
Both parents from sporadic cases 1-4 under­
went fluorescein angiography. In the 4 parents of
2 sporadic patients without an abnormal angio­
gram, all angiograms were abnormal, while in both 
parents of another sporadic case both angiograms 
were judged normal (Table 1). The genetic studies 
had proven that the parents were not gene carriers 
and their children were new mutations for
FSHD.26
Among the 130 control fluorescein angiograms 
in which a retinal vascuiopathy was not suspected, 
16 were considered technically insufficient to score 
vascular changes; 83 (73%) were found to be with­
out abnormalities; 22 (19%) were graded equivo­
cally abnormal; and 9 (8%) were considered mildly 
abnormal, i.e., vessel wall irregularities but no cap­
illary aneurysms. These figures are difficult to in­
terpret as these angiograms were made because of 
other ophthalmological pathology. The mean age 
of the control group (44 years) was similar to that 
of the FSHD patients. An age-dependent factor 
relating to the onset of retinal changes in FSHD 
appears unlikely (Table 3), as in all age groups 
approximately half of the FSHD patients reveal 
retinal vascular pathology.
Only patient JIV3 suffered noise trauma at his 
job; no one could recall having been exposed to 
ototoxic drugs. Otoscopic examination showed 
tympanic membrane scarring related to otitis me­
dia in 2 cases (B ill 1 and NIII12). After correc­
tions for age and sex19 five families (12 patients) 
proved to have a normal audiogram (Table 4). 
Twenty familial FSHD patients (62.5%) proved to 
have an abnormal audiogram, which in a similar 
rate of occurrence could be observed in the spo­
radic cases (Table 1). Of all 25 (64%) abnormal 
audiograms, 2 patients (ElVI and LEII7) showed a 
low tone deficit only, 2 patients (UII3 and HV8) 
had a low and high tone deficit, and 3 patients 
(BIII1, BIII6, and sporadic case 2) had low and 
midtone deficit in addition to a high tone hearing 
loss. Of all patients, 7 had an unilateral hearing 
loss which was in the left ear in 6» The high tone 
hearing loss was either a dip at 4000-6000 Hz or a 
steady decline after 2000 Hz.1 The hearing loss in 
the 8 parents of the sporadic cases revealed a mild 
high tone hearing loss in all but 2 parents exam­
ined. Parent P3 had a history of repeated noise 
trauma.
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Table 2. Retinal fluorescein angiography in 30 familial FSHD patients.
Chromosome 4 relation proven Chromosome 4 relation not proven
Abnormal ± Normal Abnormal ± Normal Total
3 0 3 21
2 1 1 9  
5 1 4 30
4 1 2 18
Males 9 3 3
Females 0 0 5
Patients 9 3 8
Families 6 2 3
d is c u s s io n
Retinal vascular changes and sensorineural deaf­
ness in association with a myopathy was originally 
described by Small and interpreted as an indepen­
dent genetic entity (MIM 216350).27 Subsequent 
observations recognized the myopathy as FSHD. 
The retinal vascular changes were interpreted ini­
tially as bilateral Coats’ disease, but Coats’ disease is 
defined as a usually unilateral, nonhereditary ex­
udative vascular retinopathy,13 Reports of extreme 
tortuositas and a retinal vascular disease without 
marked exudates in FSHD patients led to the non­
committal term “retinal vascular abnormalities.”21 
Different modes of inheritance, i.e., autosomal- 
recessive,18,28 autosomal-dominant,7,21 and spo­
radic15,27 cases have been suggested, and various 
associated findings such as mental retardation,15'18 
extensive muscle infiltrates,27 or respiratory fail­
ure,28 have been described that contributed to the 
speculation about genetic heterogeneity of FSHD. 
Fitzsimons et al. demonstrated retinal vascular 
changes in 75% of their autosomal-dominant 
FSHD patients.5 The discussion on the significance 
of the retinal changes were complicated by the 
finding of a retinal vascuiopathy in 8 of 30 first 
degree relatives without signs of muscle involve­
ment. Two sibs were obligatory gene carriers ac­
cording to the pedigree; 3 sibs were young, and it 
was suggested that they might develop muscle 
signs later in life; and 3 were one of the parents of 
sporadic cases. These results led to the suggestion 
that the retinopathy could be a sensitive way to 
detect a gene carrier.5
Our results demonstrating retinal vascular pa­
thology in 18 of 37 FSHD patients (49%), in whom
FIGURE 4. Sporadic case 2. Fluorescein angiogram showing 
the posterior pole with a diffusely hyperfluorescent capillary 
bed.
FIGURE 5. Sporadic case 2. Fluorescein angiogram showing 
abnormal vascular structures in the temporal inferior periph­
ery of the right eye and small and larger microaneurysms 
with capillary occlusion. Note the irregular caliber of the 
large retinal vessels.
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we could evaluate a retinal angiogram (Table 3), 
support the observations of Fitzsimons et al.5 As 
the vascular pathology can be observed by fluores­
cein angiography only in the majority of patients, 
and as the extent of the vascular changes can vary 
considerably between the two eyes while the pa­
thology often can be seen in the early phase of the 
fluorescein passage only, it is possible that the ob­
served frequency of abnormalities is lower than the 
true presence of vascular changes.
We did not observe the severe abnormalities as 
reported by Fitzsimons et al,J Our overall impres­
sion was the general tendency of mild abnormali­
ties in our patients, compared to cases pub­
lished.5,13 Also, we could not substantiate the 
retinal vascuiopathy as a reliable means to detect 
nonpenetrant gene carriers. The observation of 
retinal vascular changes in a population not stud­
ied because of a suspicion of vascuiopathy, and in 
the healthy parents of genetically proven FSHD 
mutations, casts doubts on the specificity of the 
retinal changes in FSHD. Yet its frequency in 
FSHD suggests it represents a specific entity that 
can be separated from familial retinal vascuiopathy 
with tortuositas (MIM ISOjOOO)8 by the absence of 
massive retinal hemorrhages and the presence of 
the myopathy. In idiopathic juxtafoveolar retinal 
teleangiectasis the vascuiopathy resembles the sit­
uation in FSHD, but the latter is milder and lacks
cal and laboratory features should point to the cor­
rect diagnosis. The retinal changes in the family 
reported by Storimans et al.20 resemble those of 
FSHD. We ruled out linkage with chromosome 4q 
markers in that family (data not shown). Other 
syndromes with retinal and cerebral vascular le­
sions are so distinct, because of the GNS involve­
ment, that they do not resemble FSHD.3,4,9,11’14
The same reasoning for the retinal changes ap­
plies to the sensorineural hearing loss. Brouwer et 
al.1 have already demonstrated, by comparing 
hearing function in affected and nonaffected sibs, 
that high-tone hearing loss is part of FSHD. Eigh­
teen of the present patients (family A-J) took part 
in that study. Not all patients showed a hearing 
deficit after correction for age and sex, and when 
present, there was no correlation between the se­
verity of the disease and the severity of the hearing 
loss. Also there were no systemic differences be­
tween the families.1 Our results support the thesis 
that there is no clinical difference between the 
chromosome 4-related FSHD cases and those in 
whom chromosome 4 linkage could not be proven. 
The presence of hearing loss is not an argument 
for genetic heterogeneity. In addition, the obser­
vations in our sporadic cases support the genetic 
arguments that these cases constitute new muta­
tions of the FSHD gene. However, our present re­
sults cannot decide between a contiguous gene syn­
drome or a pleiotropic effect of one gene, as we 
did not study many large families in their entirety. 
Even then, conclusions might not be definitive 
since the audiologic changes could have many 
causes, and the minimal findings of retinal vascu­
iopathy might create an interpretation problem. 
The final answer will depend on the demonstra­
tion of the molecular defect in FSHD.
The ophthalmologic and audiologic results in 
the sporadic cases suggest that they are similar to 
the autosomal-dominant cases. Based on the neu­
romuscular findings these sporadic cases represent
visual loss.6 SLE12 and diabetes mellitus might re- new mutations of FSHD. These results are sup-
semble the findings in FSHD; the additional clini-





TotalAbnormal Normal Abnormal Normal
Males 11 5 2 4 22
Females 4 2 3 1 10
Patients 15 7 5 5 32
Families 10 2 4 3 19
ported by the genetic studies, which show DNA 
rearrangements, i.e., smaller fragments, in most of 
the sporadic FSHD patients that cannot be found 
in the healthy parents.25,2b The retinal and audio­
logic changes that were found in the parents of the 
sporadic cases are difficult to explain in genetic 
terms, since the genetic studies strongly suggest 
that the parents are not nonpenetrant gene carri­
ers, and the sporadic cases are truly new muta­
tions. These findings underline the relative nature 
of the audiologic and retinal changes that have
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FIGURE 6. Autosomal-dominant case 3 (see Addendum). 
Large retinal exudate.
been studied, and support the general conclusion 
that these changes cannot serve as diagnostic cri­
teria in  questionable cases of FSHD.
ADDENDUM
After this study was completed, a survey of FSHD 
patients in The Netherlands revealed 3 cases of 
Coats’ disease among 256 patients studied (1.7%). 
Assuming a bias in reporting such cases, the true 
prevalence of a severe retinal vascuiopathy in 
FSHD is probably lower as it is assumed that 500 
symptomatic FSHD patients are alive in The Neth­
erlands. The cases we know of include a mentally 
retarded 32-year-old male (IQ 70-80) with bilat­
eral severe hearing loss, end-stage Coats disease in 
the b lind  left eye and vascular tortuosity and reti­
nal hemorrhages in the right eye.
T he  second patient was an 11-year-old mentally 
retarded boy (IQ 60—80) with an early onset spo­
radic FSH myopathy, bilateral high tone percep­
tion deafness, and a bilateral Coats syndrome, 
which had left him a vision of 0.5 in his right eye 
and no  vision in his left eye. DNA studies had not 
been performed. The third patient was a 36-year- 
old female with infantile onset of facial weakness, 
shoulder girdle and pelvic girdle weakness at the 
age o f  8, and wheelchair dependency since the age 
15. H er father had suffered from FSHD but no 
other family members were known to be affected. 
At the age of 35 she developed in a couple of hours 
a poor vision of her left eye. Fundoscopy revealed 
a large exudate (Fig. 6). Fluorescein angiography 
was not performed at that time.
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